Biomarin Pharmaceutical Inc at Jefferies Healthcare Conference (Virtual) Transcript
Hi, everyone. This Eun Yang, biotech analyst at Jefferies. It is my pleasure to host a fireside chat with the J.J. Bienaime, Chairman and CEO of BioMarin; Hank Fuchs, President of Worldwide R&D; and Brian Mueller, Chief Financial Officer. Thanks all for joining us today.
So before we start Q&A with the management team, J.J. is going to give us a short overview, and then we'll go into Q&A. J.J.?
Thank you, Eun. We appreciate the opportunity to speak with you today. As you know well, BioMarin is a fully integrated global leader in rare disease drugs, discovery, development, manufacturing and commercialization. Over the last few years, we have built a company designed for significant growth. Our global infrastructure incorporates a strong base business delivering close to $1 billion of revenues annually, a durable and scalable pipeline of innovative products and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
